FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vernon Farewell

Research Profile

Disorders

Concepts & Ideas

Physiology

Disease Progression

Activities & Behaviors

Chemicals & Drugs

Geographic Areas

Great Britain

Anatomy

Joints

Co-author Network

Publications

TOP 3
Valerie Jenkins; Carolyn Langridge; J Wagstaff; L Batt; Lesley Fallowfield; D Farewell; Vernon T Farewell
Teams Talking Trials: Results of an RCT to improve the communication of cancer teams about treatment trials.
Valerie Jenkins; Carolyn Langridge; J Wagstaff; J Darmanin; D Farewell; Vernon T Farewell; Lesley Fallowfield
Drivers and barriers to patient participation in RCTs.
Daniel M Farewell; Vernon T Farewell
Dirichlet negative multinomial regression for overdispersed correlated count data.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vernon Farewell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Valerie Jenkins; Carolyn Langridge; J Wagstaff; L Batt; Lesley Fallowfield; D Farewell; Vernon T Farewell
Teams Talking Trials: Results of an RCT to improve the communication of cancer teams about treatment trials.
Contemporary clinical trials 2013;35(1):43-51.
2013: Valerie Jenkins; Carolyn Langridge; J Wagstaff; J Darmanin; D Farewell; Vernon T Farewell; Lesley Fallowfield
Drivers and barriers to patient participation in RCTs.
British journal of cancer 2013;108(7):1402-7.
2013: Daniel M Farewell; Vernon T Farewell
Dirichlet negative multinomial regression for overdispersed correlated count data.
Biostatistics (Oxford, England) 2013;14(2):395-404.
2013: Aidan G O'Keeffe; Brian D M Tom; Vernon T Farewell
Mixture distributions in multi-state modelling: Some considerations in a study of psoriatic arthritis.
Statistics in medicine 2013;32(4):600-19.
2012: Jessica K Barrett; Vernon T Farewell; Fotios Siannis; Jayne Tierney; Julian P T Higgins
Two-stage meta-analysis of survival data from individual participants using percentile ratios.
Statistics in medicine 2012;31(30):4296-308.
2012: Chee-Seng Yee; Munther Khamashta; Rachael Kilding; Mohammed Akil; Rupa Bessant; Vernon T Farewell; Ian Giles; Caroline Gordon
The BILAG2004-Pregnancy index is reliable for assessment of disease activity in pregnant SLE patients.
Rheumatology (Oxford, England) 2012;51(10):1877-80.
2012: John G Hanly; Antonina Omisade; Li Su; Vernon T Farewell; John D Fisk
Screening for cognitive impairment in systemic lupus erythematosus.
The Journal of rheumatology 2012;39(7):1371-7.
2012: Janice A Husted; Brian D Tom; Vernon T Farewell; Dafna D Gladman
Longitudinal study of the bidirectional association between pain and depressive symptoms in patients with psoriatic arthritis.
Arthritis care & research 2012;64(5):758-65.
2011: R Pollock; Vinod Chandran; J Barrett; L Eder; Fawnda Pellett; C Yao; M Lino; S Shanmugarajah; Vernon T Farewell; Dafna D Gladman
Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease.
Tissue antigens 2011;77(6):554-61.
2011: E Ford; Valerie Jenkins; Lesley Fallowfield; N Stuart; D Farewell; Vernon T Farewell
Clinicians' attitudes towards clinical trials of cancer therapy.
British journal of cancer 2011;104(10):1535-43.
2011: Chee-Seng Yee; Vernon T Farewell; David A Isenberg; Bridget Griffiths; Lee-Suan Teh; Ian Bruce; Yasmeen Ahmad; Anisur Rahman; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; Christopher Edwards; David D'Cruz; Munther A Khamashta; Caroline Gordon
The use of Systemic Lupus Erythematosus Disease Activity Index-2000 to define active disease and minimal clinically meaningful change based on data from a large cohort of systemic lupus erythematosus patients.
Rheumatology (Oxford, England) 2011;50(5):982-8.
2011: Lynne Cresswell; Vinod Chandran; Vernon T Farewell; Dafna D Gladman
Inflammation in an individual joint predicts damage to that joint in psoriatic arthritis.
Annals of the rheumatic diseases 2011;70(2):305-8.
2011: Jessica K Barrett; Fotios Siannis; Vernon T Farewell
A semi-competing risks model for data with interval-censoring and informative observation: an application to the MRC cognitive function and ageing study.
Statistics in medicine 2011;30(1):1-10.
2011: David A Isenberg; Elizabeth Allen; Vernon T Farewell; David D'Cruz; G S Alarcón; C Aranow; Ian N Bruce; Mary Anne Dooley; P R Fortin; E M Ginzler; D D Gladman; J G Hanly; M Inanc; K Kalunian; Munther A Khamashta; J T Merrill; O Nived; Michelle Petri; R Ramsey-Goldman; G Sturfelt; M Urowitz; D J Wallace; Caroline Gordon; Anisur Rahman
An assessment of disease flare in patients with systemic lupus erythematosus: a comparison of BILAG 2004 and the flare version of SELENA.
Annals of the rheumatic diseases 2011;70(1):54-9.
2011: Vernon T Farewell; Li Su
A multistate model for events defined by prolonged observation.
Biostatistics (Oxford, England) 2011;12(1):102-11.
2010: Fotios Siannis; J K Barrett; Vernon T Farewell; J F Tierney
One-stage parametric meta-analysis of time-to-event outcomes.
Statistics in medicine 2010;29(29):3030-45.
2010: Valerie Jenkins; D Farewell; L Batt; T Maughan; L Branston; Carolyn Langridge; L Parlour; Vernon T Farewell; Lesley Fallowfield
The attitudes of 1066 patients with cancer towards participation in randomised clinical trials.
British journal of cancer 2010;103(12):1801-7.
2010: Dafna D Gladman; Brian D M Tom; Philip J Mease; Vernon T Farewell
Informing response criteria for psoriatic arthritis (PsA). II: Further considerations and a proposal--the PsA joint activity index.
The Journal of rheumatology 2010;37(12):2559-65.
2010: Janice Husted; Brian D M Tom; Vernon T Farewell; Dafna D Gladman
Longitudinal analysis of fatigue in psoriatic arthritis.
The Journal of rheumatology 2010;37(9):1878-84.
2010: Dafna D Gladman; Brian D M Tom; Philip J Mease; Vernon T Farewell
Informing response criteria for psoriatic arthritis. I: discrimination models based on data from 3 anti-tumor necrosis factor randomized studies.
The Journal of rheumatology 2010;37(9):1892-7.
2010: Chee-Seng Yee; Lynne Cresswell; Vernon T Farewell; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; David A Isenberg; Caroline Gordon
Numerical scoring for the BILAG-2004 index.
Rheumatology (Oxford, England) 2010;49(9):1665-9.
2010: Lesley Fallowfield; A Fleissig; J Barrett; U Menon; I Jacobs; J Kilkerr; Vernon T Farewell
Awareness of ovarian cancer risk factors, beliefs and attitudes towards screening: baseline survey of 21,715 women participating in the UK Collaborative Trial of Ovarian Cancer Screening.
British journal of cancer 2010;103(4):454-61.
2010: Vinod Chandran; Fotios Siannis; Proton Rahman; Fawnda J Pellett; Vernon T Farewell; Dafna D Gladman
Folate pathway enzyme gene polymorphisms and the efficacy and toxicity of methotrexate in psoriatic arthritis.
The Journal of rheumatology 2010;37(7):1508-12.
2010: Michael J Sweeting; Vernon T Farewell; Daniela De Angelis
Multi-state Markov models for disease progression in the presence of informative examination times: an application to hepatitis C.
Statistics in medicine 2010;29(11):1161-74.
2010: Vernon T Farewell; Richard J Cook
Clinical trials: planning and analysis.
Endocrine development 2010;18():1-22.
2009: Vinod Chandran; Jessica Barrett; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Axial psoriatic arthritis: update on a longterm prospective study.
The Journal of rheumatology 2009;36(12):2744-50.
2009: Lynne Cresswell; Chee-Seng Yee; Vernon T Farewell; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian N Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; Veronica Toescu; David D'Cruz; Munther A Khamashta; Peter Maddison; David A Isenberg; Caroline Gordon
Numerical scoring for the Classic BILAG index.
Rheumatology (Oxford, England) 2009;48(12):1548-52.
2009: Vernon T Farewell; B D M Tom
Commentary on 'Measurement in clinical trials: a neglected issue for statisticians?'.
Statistics in medicine 2009;28(26):3210-2; discussion 3223-5.
2009: Janice Husted; Brian D M Tom; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Occurrence and correlates of fatigue in psoriatic arthritis.
Annals of the rheumatic diseases 2009;68(10):1553-8.
2009: Chee-Seng Yee; Vernon T Farewell; David A Isenberg; Bridget Griffiths; Lee-Suan Teh; Ian N Bruce; Yasmeen Ahmad; Anisur Rahman; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; Christopher Edwards; David D'Cruz; Munther A Khamashta; Peter Maddison; Caroline Gordon
The BILAG-2004 index is sensitive to change for assessment of SLE disease activity.
Rheumatology (Oxford, England) 2009;48(6):691-5.
2009: Li Su; Brian D M Tom; Vernon T Farewell
Bias in 2-part mixed models for longitudinal semicontinuous data.
Biostatistics (Oxford, England) 2009;10(2):374-89.
2009: Dafna D Gladman; Catherine T Schentag; B D M Tom; V Chandran; J Brockbank; C Rosen; Vernon T Farewell
Development and initial validation of a screening questionnaire for psoriatic arthritis: the Toronto Psoriatic Arthritis Screen (ToPAS).
Annals of the rheumatic diseases 2009;68(4):497-501.
2009: Brian D M Tom; Vernon T Farewell
Comments on "A hierarchical zero-inflated log-normal model for skewed responses".
Statistical methods in medical research 2009;18(1):107-8; discussion 108-9.
2008: Murray B Urowitz; Dafna D Gladman; Brian D M Tom; Dominique Ibañez; Vernon T Farewell
Changing patterns in mortality and disease outcomes for patients with systemic lupus erythematosus.
The Journal of rheumatology 2008;35(11):2152-8.
2008: Proton Rahman; Tara Snelgrove; Lynette Peddle; Fotios Siannis; Vernon T Farewell; Catherine T Schentag; Dafna Gladman
A variant of the IL4 I50V single-nucleotide polymorphism is associated with erosive joint disease in psoriatic arthritis.
Arthritis and rheumatism 2008;58(7):2207-8.
2008: Sherry Rohekar; Brian D M Tom; Agnes Hassa; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Prevalence of malignancy in psoriatic arthritis.
Arthritis and rheumatism 2008;58(1):82-7.
2007: Chee-Seng Yee; Vernon T Farewell; David A Isenberg; Anisur Rahman; Lee-Suan Teh; Bridget Griffiths; Ian N Bruce; Yasmeen Ahmad; Athiveeraramapandian Prabu; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; Peter Maddison; Caroline Gordon
British Isles Lupus Assessment Group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus.
Arthritis and rheumatism 2007;56(12):4113-9.
2007: Yaser Ali; Brian D M Tom; Catherine T Schentag; Vernon T Farewell; Dafna D Gladman
Improved survival in psoriatic arthritis with calendar time.
Arthritis and rheumatism 2007;56(8):2708-14.
2007: Janice Husted; Brian D M Tom; Vernon T Farewell; Catherine T Schentag; Dafna D Gladman
A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: Does the effect change over time?
Arthritis and rheumatism 2007;56(3):840-9.
2007: Simon J Bond; Vernon T Farewell; Catherine T Schentag; Dafna D Gladman
Predictors for radiological damage in psoriatic arthritis: results from a single centre.
Annals of the rheumatic diseases 2007;66(3):370-6.
2007: Fotios Siannis; Vernon T Farewell; J Head
A multi-state model for joint modelling of terminal and non-terminal events with application to Whitehall II.
Statistics in medicine 2007;26(2):426-42.
2006: Chee-Seng Yee; Vernon T Farewell; David A Isenberg; Athiveeraramapandian Prabu; Katharina Sokoll; Lee-Suan Teh; Anisur Rahman; Ian N Bruce; Bridget Griffiths; Mohammed Akil; Neil McHugh; David D'Cruz; Munther A Khamashta; Simon Bowman; Peter Maddison; Asad Zoma; Elizabeth Allen; Caroline Gordon
Revised British Isles Lupus Assessment Group 2004 index: a reliable tool for assessment of systemic lupus erythematosus activity.
Arthritis and rheumatism 2006;54(10):3300-5.
2006: Vernon T Farewell; Tony Johnson; Peter Armitage
'A memorandum on the Present Position and Prospects of Medical Statistics and Epidemiology' by Major Greenwood.
Statistics in medicine 2006;25(13):2161-77.
2006: Proton Rahman; Fotios Siannis; Christopher Butt; Vernon T Farewell; Lynette Peddle; Fawnda Pellett; Dafna Gladman
TNFalpha polymorphisms and risk of psoriatic arthritis.
Annals of the rheumatic diseases 2006;65(7):919-23.
2006: Fotios Siannis; Vernon T Farewell; Richard J Cook; Catherine T Schentag; Dafna D Gladman
Clinical and radiological damage in psoriatic arthritis.
Annals of the rheumatic diseases 2006;65(4):478-81.
2006: E Allen; Vernon T Farewell; David A Isenberg; Caroline Gordon
A statistical analysis of the interrelationships between disease activity in different systems in systemic lupus erythematosus.
Rheumatology (Oxford, England) 2006;45(3):308-13.
2006: Ivonne L Solís-Trápala; Vernon T Farewell
A note on robust inference from a conditional Poisson model.
Biometrical journal. Biometrische Zeitschrift 2006;48(1):117-30.
2005: Simon Bond; Vernon T Farewell; Catherine T Schentag; Jerald F Lawless; Dafna D Gladman
Reporting of mortality in a psoriatic arthritis clinic is primarily a function of the number of clinic contacts and not disease severity.
The Journal of rheumatology 2005;32(12):2364-7.
2005: Vernon T Farewell; A M Herzberg; K W James; L M Ho; G M Leung
SARS incubation and quarantine times: when is an exposed individual known to be disease free?
Statistics in medicine 2005;24(22):3431-45.
2005: Proton Rahman; Christopher Butt; Fotios Siannis; Vernon T Farewell; Lynette Peddle; Fawnda Pellett; Catherine T Schentag; Dafna D Gladman
Association of SEEK1 and psoriatic arthritis in two distinct Canadian populations.
Annals of the rheumatic diseases 2005;64(9):1370-2.
2005: Dafna D Gladman; Tabitha N Kung; Fotios Siannis; Fawnda Pellett; Vernon T Farewell; Peter Lee
HLA markers for susceptibility and expression in scleroderma.
The Journal of rheumatology 2005;32(8):1481-7.
2005: David A Isenberg; Anisur Rahman; E Allen; Vernon T Farewell; Mohammed Akil; Ian N Bruce; David D'Cruz; Bridget Griffiths; Munther A Khamashta; P Maddison; N McHugh; Michael Snaith; Lee-Suan Teh; Chee-Seng Yee; Asad Zoma; Caroline Gordon
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 2005;44(7):902-6.
2005: Janice Husted; Brian D M Tom; Vernon T Farewell; Catherine T Schentag; Dafna D Gladman
Description and prediction of physical functional disability in psoriatic arthritis: a longitudinal analysis using a Markov model approach.
Arthritis and rheumatism 2005;53(3):404-9.
2005: Christopher Butt; Proton Rahman; Fotios Siannis; Vernon T Farewell; Dafna D Gladman
Corneodesmosin polymorphisms in psoriatic arthritis.
Rheumatology (Oxford, England) 2005;44(5):684-5.
2005: Dafna D Gladman; Vernon T Farewell
Longitudinal cohort studies.
The Journal of rheumatology. Supplement 2005;72():30-2.
2004: Sean J Wollaston; Vernon T Farewell; David A Isenberg; Caroline Gordon; Joan T Merrill; Michelle Petri; Kenneth C Kalunian
Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.
The Journal of rheumatology 2004;31(12):2390-4.
2004: Vernon T Farewell
Studies of attrition in rheumatological databases.
The Journal of rheumatology 2004;31(7):1244-5.
2004: Olivia Grigg; Vernon T Farewell
A risk-adjusted Sets method for monitoring adverse medical outcomes.
Statistics in medicine 2004;23(10):1593-602.
2004: David A Isenberg; E Allen; Vernon T Farewell; Michael R Ehrenstein; Michael G Hanna; Ingrid E Lundberg; Chester V Oddis; Clarissa Pilkington; Paul H Plotz; David Scott; Jiri Vencovsky; R Cooper; Lisa G Rider; F Miller
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
Rheumatology (Oxford, England) 2004;43(1):49-54.
2003: Lesley Fallowfield; Valerie Jenkins; Vernon T Farewell; I Solis-Trapala
Enduring impact of communication skills training: results of a 12-month follow-up.
British journal of cancer 2003;89(8):1445-9.
2003: Dafna D Gladman; Vernon T Farewell; Fawnda Pellett; Catherine T Schentag; Proton Rahman
HLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairs.
Human immunology 2003;64(9):887-9.
2003: Proton Rahman; Sylvia Bartlett; Fotios Siannis; Fawnda Pellett; Vernon T Farewell; Lynette Peddle; Catherine T Schentag; Catherine Alderdice; Sean Hamilton; Majed M Khraishi; Yvonne M Tobin; Donna Hefferton; Dafna D Gladman
CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis.
American journal of human genetics 2003;73(3):677-81.
2003: David A Cook; Stefan H Steiner; Richard J Cook; Vernon T Farewell; Anthony P Morton
Monitoring the evolutionary process of quality: risk-adjusted charting to track outcomes in intensive care.
Critical care medicine 2003;31(6):1676-82.
2003: Olivia Grigg; Vernon T Farewell; David J Spiegelhalter
Use of risk-adjusted CUSUM and RSPRT charts for monitoring in medical contexts.
Statistical methods in medical research 2003;12(2):147-70.
2003: Dafna D Gladman; Vernon T Farewell
HLA studies in psoriatic arthritis: current situation and future needs.
The Journal of rheumatology 2003;30(1):4-6.
2002: Peter Maddison; Vernon T Farewell; David Isenberg; Cynthia Aranow; Sang-Cheol Bae; Susan Barr; Jill P Buyon; Paul Fortin; Ellen M Ginzler; Dafna Gladman; John G Hanly; Susan Manzi; Ola Nived; Michelle Petri; Rosalind Ramsey-Goldman; Gunnar Sturfelt
The rate and pattern of organ damage in late onset systemic lupus erythematosus.
The Journal of rheumatology 2002;29(5):913-7.
2002: Lesley Fallowfield; Valerie Jenkins; Vernon T Farewell; Jacky Saul; Anthony Duffy; Rebecca Eves
Efficacy of a Cancer Research UK communication skills training model for oncologists: a randomised controlled trial.
Lancet 2002;359(9307):650-6.
2001: Frederick W Miller; Lisa G Rider; Y L Chung; R Cooper; K Danko; Vernon T Farewell; I Lundberg; C Morrison; L Oakley; I Oakley; Clarissa Pilkington; Jiri Vencovsky; K Vincent; David Scott; David A Isenberg
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
Rheumatology (Oxford, England) 2001;40(11):1262-73.
2001: Dafna D Gladman; Vernon T Farewell; Proton Rahman; Catherine T Schentag; Fawnda Pellett; CM Ng; Judith A Wade
HLA-DRB1*04 alleles in psoriatic arthritis: comparison with rheumatoid arthritis and healthy controls.
Human immunology 2001;62(11):1239-44.
2001: Stefan H Steiner; Richard J Cook; Vernon T Farewell
Risk-adjusted monitoring of binary surgical outcomes.
Medical decision making : an international journal of the Society for Medical Decision Making 2001;21(3):163-9.
2001: Janice Husted; Dafna D Gladman; Vernon T Farewell; Richard J Cook
Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.
Arthritis and rheumatism 2001;45(2):151-8.
2000: Stefan H Steiner; Richard J Cook; Vernon T Farewell; T Treasure
Monitoring surgical performance using risk-adjusted cumulative sum charts.
Biostatistics (Oxford, England) 2000;1(4):441-52.
2000: Janice Husted; Richard J Cook; Vernon T Farewell; Dafna D Gladman
Methods for assessing responsiveness: a critical review and recommendations.
Journal of clinical epidemiology 2000;53(5):459-68.
2000: JA Long; Janice Husted; Dafna D Gladman; Vernon T Farewell
The relationship between patient satisfaction with health and clinical measures of function and disease status in patients with psoriatic arthritis.
The Journal of rheumatology 2000;27(4):958-66.
1999: Nurhan Sutcliffe; Ann E Clarke; Caroline Gordon; Vernon T Farewell; David A Isenberg
The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus.
Rheumatology (Oxford, England) 1999;38(11):1130-7.
1999: Dafna D Gladman; Vernon T Farewell
Progression in psoriatic arthritis: role of time varying clinical indicators.
The Journal of rheumatology 1999;26(11):2409-13.
1999: Vernon T Farewell; D A Sprott
Conditional inference for predictive agreement.
Statistics in medicine 1999;18(12):1435-49.
1999: Stefan H Steiner; Richard J Cook; Vernon T Farewell
Monitoring paired binary surgical outcomes using cumulative sum charts.
Statistics in medicine 1999;18(1):69-86.
1998: Janice Husted; Dafna D Gladman; Richard J Cook; Vernon T Farewell
Responsiveness of health status instruments to changes in articular status and perceived health in patients with psoriatic arthritis.
The Journal of rheumatology 1998;25(11):2146-55.
1998: Dafna D Gladman; Vernon T Farewell; K Wong; Janice Husted
Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.
Arthritis and rheumatism 1998;41(6):1103-10.
1998: Dafna D Gladman; Vernon T Farewell; K A Kopciuk; Richard J Cook
HLA markers and progression in psoriatic arthritis.
The Journal of rheumatology 1998;25(4):730-3.
1997: K Wong; Dafna D Gladman; Janice Husted; JA Long; Vernon T Farewell
Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death.
Arthritis and rheumatism 1997;40(10):1868-72.
1997: Murray B Urowitz; Dafna D Gladman; M Abu-Shakra; Vernon T Farewell
Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years.
The Journal of rheumatology 1997;24(6):1061-5.
1997: Janice Husted; Dafna D Gladman; Vernon T Farewell; JA Long; Richard J Cook
Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis.
The Journal of rheumatology 1997;24(3):511-7.
1996: Janice Husted; D D Gladman; J A Long; Vernon T Farewell
Relationship of the Arthritis Impact Measurement Scales to changes in articular status and functional performance in patients with psoriatic arthritis.
The Journal of rheumatology 1996;23(11):1932-7.
1996: Janice Husted; D D Gladman; Vernon T Farewell; J A Long
Validation of the revised and expanded version of the Arthritis Impact Measurement Scales for patients with psoriatic Arthritis.
The Journal of rheumatology 1996;23(6):1015-9.
1995: Mahmoud Abu-Shakra; D D Gladman; Murray B Urowitz; Vernon T Farewell
Anticardiolipin antibodies in systemic lupus erythematosus: clinical and laboratory correlations.
The American journal of medicine 1995;99(6):624-8.
1995: Janice Husted; D D Gladman; J A Long; Vernon T Farewell
A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis.
Clinical and experimental rheumatology 1995;13(4):439-43.
1995: D D Gladman; Vernon T Farewell
The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model.
Arthritis and rheumatism 1995;38(6):845-50.
1995: M G Blackmore; D D Gladman; Janice Husted; J A Long; Vernon T Farewell
Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification.
The Journal of rheumatology 1995;22(5):886-93.
1995: D D Gladman; Vernon T Farewell; C Nadeau
Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model.
The Journal of rheumatology 1995;22(4):675-9.
1995: R Mader; D D Gladman; J Long; J Gough; Vernon T Farewell
Does injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?
Clinical and investigative medicine. Médecine clinique et experimentale 1995;18(2):139-43.
1995: Mahmoud Abu-Shakra; D D Gladman; J C Thorne; J Long; J Gough; Vernon T Farewell
Longterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcome.
The Journal of rheumatology 1995;22(2):241-5.
1994: J R McLaughlin; C Bombardier; Vernon T Farewell; D D Gladman; Murray B Urowitz
Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables.
Arthritis and rheumatism 1994;37(4):559-67.
1993: Murray B Urowitz; D D Gladman; Vernon T Farewell; J Stewart; J McDonald
Lupus and pregnancy studies.
Arthritis and rheumatism 1993;36(10):1392-7.
1993: D D Gladman; B Brubacher; D Buskila; P Langevitz; Vernon T Farewell
Differences in the expression of spondyloarthropathy: a comparison between ankylosing spondylitis and psoriatic arthritis.
Clinical and investigative medicine. Médecine clinique et experimentale 1993;16(1):1-7.
1992: Ciarán M Duffy; K N Watanabe Duffy; D D Gladman; B B Brubacher; D Buskila; P Langevitz; Vernon T Farewell
The utility of the arthritis impact measurement scales for patients with psoriatic arthritis.
The Journal of rheumatology 1992;19(11):1727-32.
1992: D D Gladman; R Blake; B Brubacher; Vernon T Farewell
Chloroquine therapy in psoriatic arthritis.
The Journal of rheumatology 1992;19(11):1724-6.
1992: D D Gladman; B Brubacher; D Buskila; P Langevitz; Vernon T Farewell
Psoriatic spondyloarthropathy in men and women: a clinical, radiographic, and HLA study.
Clinical and investigative medicine. Médecine clinique et experimentale 1992;15(4):371-5.
1992: B Brubacher; D D Gladman; D Buskila; P Langevitz; Vernon T Farewell
Followup in psoriatic arthritis: relationship to disease characteristics.
The Journal of rheumatology 1992;19(6):917-20.
1991: J McLaughlin; D D Gladman; Murray B Urowitz; C Bombardier; Vernon T Farewell; Edward Cole
Kidney biopsy in systemic lupus erythematosus. II. Survival analyses according to biopsy results.
Arthritis and rheumatism 1991;34(10):1268-73.